| 000 | 01305 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513170356.0 | ||
| 264 | 0 | _c19990601 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0049-3848 | ||
| 024 | 7 |
_a10.1016/s0049-3848(98)00182-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeblond, L | |
| 245 | 0 | 0 |
_aInsertion of the Asp-Ser/Phe sequence in the P' position of hirutonin provides molecules having both antithrombin and disintegrin activity. _h[electronic resource] |
| 260 |
_bThrombosis research _cFeb 1999 |
||
| 300 |
_a171-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntithrombins _xchemistry |
| 650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
| 650 | 0 | 4 |
_aDisintegrins _xchemistry |
| 650 | 0 | 4 |
_aHirudins _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aProtein Engineering |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aDiMaio, J | |
| 700 | 1 | _aWinocour, P D | |
| 773 | 0 |
_tThrombosis research _gvol. 93 _gno. 4 _gp. 171-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0049-3848(98)00182-0 _zAvailable from publisher's website |
| 999 |
_c10024525 _d10024525 |
||